Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2011

Open Access 01-12-2011 | Research article

Creating scenarios of the impact of copd and their relationship to copd assessment test (CAT™) scores

Authors: Paul W Jones, Margaret Tabberer, Wen-Hung Chen

Published in: BMC Pulmonary Medicine | Issue 1/2011

Login to get access

Abstract

Background

The COPD Assessment Test (CAT™) is a new short health status measure for routine use. New questionnaires require reference points so that users can understand the scores; descriptive scenarios are one way of doing this. A novel method of creating scenarios is described.

Methods

A Bland and Altman plot showed a consistent relationship between CAT scores and scores obtained with the St George's Respiratory Questionnaire for COPD (SGRQ-C) permitting a direct mapping process between CAT and SGRQ items. The severity associated with each CAT item was calculated using a probabilistic model and expressed in logits (log odds of a patient of given severity affirming that item 50% of the time). Severity estimates for SGRQ-C items in logits were also available, allowing direct comparisons with CAT items. CAT scores were categorised into Low, Medium, High and Very High Impact. SGRQ items of corresponding severity were used to create scenarios associated with each category.

Results

Each CAT category was associated with a scenario comprising 12 to 16 SGRQ-C items. A severity 'ladder' associating CAT scores with exemplar health status effects was also created. Items associated with 'Low' and 'Medium' Impact appeared to be subjectively quite severe in terms of their effect on daily life.

Conclusions

These scenarios provide users of the CAT with a good sense of the health impact associated with different scores. More generally they provide a surprising insight into the severity of the effects of COPD, even in patients with apparently mild-moderate health status impact.
Appendix
Available only for authorised users
Literature
1.
go back to reference Global Initiative for Chronic Obstructive Lung Disease (GOLD) guideline: Global Strategy for the Diagnosis, management and Prevention of Chronic Obstructive Pulmonary Disease (updated 2009). last accessed 12 May 2011, [http://www.goldcopd.com] Global Initiative for Chronic Obstructive Lung Disease (GOLD) guideline: Global Strategy for the Diagnosis, management and Prevention of Chronic Obstructive Pulmonary Disease (updated 2009). last accessed 12 May 2011, [http://​www.​goldcopd.​com]
2.
go back to reference Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, Brusasco V, Burge PS, Calverley PM, Celli BR, Jones PW, Mahler DA, Make B, Miravitlles M, Page CP, Palange P, Parr D, Pistolesi M, Rennard SI, Rutten-van Mölken MP, Stockley R, Sullivan SD, Wedzicha JA, Wouters EF, American Thoracic Society; European Respiratory Society Task Force on outcomes of COPD: Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J. 2008, 31: 416-469. 10.1183/09031936.00099306.CrossRefPubMed Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, Brusasco V, Burge PS, Calverley PM, Celli BR, Jones PW, Mahler DA, Make B, Miravitlles M, Page CP, Palange P, Parr D, Pistolesi M, Rennard SI, Rutten-van Mölken MP, Stockley R, Sullivan SD, Wedzicha JA, Wouters EF, American Thoracic Society; European Respiratory Society Task Force on outcomes of COPD: Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J. 2008, 31: 416-469. 10.1183/09031936.00099306.CrossRefPubMed
3.
go back to reference Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW: A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987, 42: 773-778. 10.1136/thx.42.10.773.CrossRefPubMedPubMedCentral Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW: A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987, 42: 773-778. 10.1136/thx.42.10.773.CrossRefPubMedPubMedCentral
4.
go back to reference van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF: Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003, 1: 13-10.1186/1477-7525-1-13. 28CrossRefPubMedPubMedCentral van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF: Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003, 1: 13-10.1186/1477-7525-1-13. 28CrossRefPubMedPubMedCentral
5.
go back to reference Jones PW, Quirk FH, Baveystock CM: The St George's Respiratory Questionnaire. Respir Med. 1991, 85 (Suppl B): 25-31.CrossRefPubMed Jones PW, Quirk FH, Baveystock CM: The St George's Respiratory Questionnaire. Respir Med. 1991, 85 (Suppl B): 25-31.CrossRefPubMed
6.
go back to reference Meguro M, Barley EA, Spencer S, Jones PW: Development and validation of an improved COPD-specific version of the St George's Respiratory Questionnaire. Chest. 2006, 132: 456-463.CrossRef Meguro M, Barley EA, Spencer S, Jones PW: Development and validation of an improved COPD-specific version of the St George's Respiratory Questionnaire. Chest. 2006, 132: 456-463.CrossRef
7.
go back to reference Jones PW: St. George's Respiratory Questionnaire: MCID. COPD. 2005, 2: 75-79. 10.1081/COPD-200050513.CrossRefPubMed Jones PW: St. George's Respiratory Questionnaire: MCID. COPD. 2005, 2: 75-79. 10.1081/COPD-200050513.CrossRefPubMed
8.
go back to reference Jones PW: Interpreting thresholds for a clinically significant changes in health status in asthma and COPD. Eur Respir J. 2002, 19: 398-404. 10.1183/09031936.02.00063702.CrossRefPubMed Jones PW: Interpreting thresholds for a clinically significant changes in health status in asthma and COPD. Eur Respir J. 2002, 19: 398-404. 10.1183/09031936.02.00063702.CrossRefPubMed
9.
go back to reference Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N: Development and first validation of the COPD Assessment Test. Eur Respir J. 2009, 34: 648-654. 10.1183/09031936.00102509.CrossRefPubMed Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N: Development and first validation of the COPD Assessment Test. Eur Respir J. 2009, 34: 648-654. 10.1183/09031936.00102509.CrossRefPubMed
10.
go back to reference Jones P, Harding G, Wiklund I, Berry P, Leidy N: Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J. 2009, 18: 208-215. 10.4104/pcrj.2009.00053.CrossRefPubMed Jones P, Harding G, Wiklund I, Berry P, Leidy N: Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J. 2009, 18: 208-215. 10.4104/pcrj.2009.00053.CrossRefPubMed
11.
go back to reference Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986, 1: 307-310.CrossRefPubMed Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986, 1: 307-310.CrossRefPubMed
12.
go back to reference Rasch G: Probabilistic models for some intelligence and attainment tests. AA. 1960, Chicago: University of Chicago Press Rasch G: Probabilistic models for some intelligence and attainment tests. AA. 1960, Chicago: University of Chicago Press
13.
go back to reference Barley EA, Jones PW: Repeatability of a Rasch model of the AQ20 over five assessments. Qual Life Res. 2006, 15: 801-809. 10.1007/s11136-005-5466-z.CrossRefPubMed Barley EA, Jones PW: Repeatability of a Rasch model of the AQ20 over five assessments. Qual Life Res. 2006, 15: 801-809. 10.1007/s11136-005-5466-z.CrossRefPubMed
14.
go back to reference Andrich D, Sheridon BE, Luo G: RUMM2020 (Rasch unidimensional measurement models). AA. 2005, Perth: RUMM Laboratory Andrich D, Sheridon BE, Luo G: RUMM2020 (Rasch unidimensional measurement models). AA. 2005, Perth: RUMM Laboratory
15.
go back to reference Hawthorne G, Densley K, Pallant JF, Mortimer D, Segal L: Deriving utility scores from the SF-36 health instrument using Rasch analysis. Qual Life Res. 2008, 17: 1183-1193. 10.1007/s11136-008-9395-5.CrossRefPubMed Hawthorne G, Densley K, Pallant JF, Mortimer D, Segal L: Deriving utility scores from the SF-36 health instrument using Rasch analysis. Qual Life Res. 2008, 17: 1183-1193. 10.1007/s11136-008-9395-5.CrossRefPubMed
16.
go back to reference Young TA, Rowen D, Norquist J, Brazier JE: Developing preference-based health measures: using Rasch analysis to generate health state values. Qual Life Res. 2010, 19: 907-917. 10.1007/s11136-010-9646-0.CrossRefPubMed Young TA, Rowen D, Norquist J, Brazier JE: Developing preference-based health measures: using Rasch analysis to generate health state values. Qual Life Res. 2010, 19: 907-917. 10.1007/s11136-010-9646-0.CrossRefPubMed
Metadata
Title
Creating scenarios of the impact of copd and their relationship to copd assessment test (CAT™) scores
Authors
Paul W Jones
Margaret Tabberer
Wen-Hung Chen
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2011
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-11-42

Other articles of this Issue 1/2011

BMC Pulmonary Medicine 1/2011 Go to the issue